Who
Jill M. Jene
Director
Company insider
Files Form 4 as: Director, Lipocine; VP, Business Development, Pdl Biopharma.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 25 Sep 2018
- Last trade
- 3 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 4 Jun 2026 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $3,8631,764 at $2.19 | filing |
| 3 Jun 2026filed 4 Jun 2026 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $3,8631,764 at $2.19 | filing |
| 4 Jun 2025filed 5 Jun 2025 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $5,6451,764 at $3.20 | filing |
| 5 Jun 2024filed 7 Jun 2024 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $12K1,764 at $7.05 | filing |
| 10 May 2023filed 12 May 2023 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $8,10030,000 at $0.27 | filing |
| 8 Jun 2022filed 10 Jun 2022 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $20K22,000 at $0.92 | filing |
| 11 Apr 2022filed 12 Apr 2022 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $12K10,000 at $1.16 | filing |
| 8 Jan 2020filed 7 Apr 2020 | Pdl Biopharma | SEC FORM 4 Code A | —194,805 at $0.00 | filing |
| 8 Jan 2020filed 10 Jan 2020 | Pdl Biopharma | SEC FORM 4 Code A | —194,805 at $0.00 | filing |
| 28 Mar 2019filed 16 Apr 2019 | Pdl Biopharmaoption or derivative | SEC FORM 4 Code A | —384,615 at $0.00 | filing |
| 28 Mar 2019filed 1 Apr 2019 | Pdl Biopharmaoption or derivative | SEC FORM 4 Code A | —377,358 at $0.00 | filing |
| 25 Sep 2018filed 27 Sep 2018 | Pdl Biopharmaoption or derivative | SEC FORM 4 Code A | —377,358 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.
Related people
Nobody else traded the same names lately.